Rankings
▼
Calendar
EYPT
EyePoint Pharmaceuticals, Inc.
$1B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
Gross Profit
$3M
47.0% margin
Operating Income
-$94,000
-1.6% margin
Net Income
-$67,000
-1.1% margin
EPS (Diluted)
$-0.02
QoQ Revenue Growth
+2055.6%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$396,000
Balance Sheet
Total Assets
$20M
Total Liabilities
$5M
Stockholders' Equity
$15M
Cash & Equivalents
$12M
← Q3 2016
All Quarters
Q1 2017 →
EYPT Q4 2016 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
